Singular effects of PPAR agonists on nonalcoholic fatty liver disease of diet-induced obese mice

Aguila, 2010, Hepatic insulin resistance and nonalcoholic fatty liver disease, 1 Chen, 2014, PPARs and metabolic syndrome, PPAR Res., 832606 Tenenbaum, 2005, Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons, Cardiovasc. Diabetol., 4, 14, 10.1186/1475-2840-4-14 Liu, 2011, Role of peroxisome proliferator-activated receptor {delta}/{beta} in hepatic metabolic regulation, J. Biol. Chem., 286, 1237, 10.1074/jbc.M110.138115 Fraulob, 2012, Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet, Clin. Sci. (Lond.), 123, 259, 10.1042/CS20110373 Ferramosca, 2014, Modulation of hepatic steatosis by dietary fatty acids, World J. Gastroenterol., 20, 1746, 10.3748/wjg.v20.i7.1746 Reeves, 1993, AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet, J. Nutr., 123, 1939, 10.1093/jn/123.11.1939 Souza-Mello, 2007, Hepatic structural alteration in adult programmed offspring (severe maternal protein restriction) is aggravated by post-weaning high-fat diet, Br. J. Nutr., 98, 1159, 10.1017/S0007114507771878 Yin, 1982, Use of tibial length to quantify cardiac hypertrophy: application in the aging rat, Am. J. Physiol., 243, H941 Catta-Preta, 2011, A critical analysis of three quantitative methods of assessment of hepatic steatosis in liver biopsies, Virchows Arch., 459, 477, 10.1007/s00428-011-1147-1 Aguila, 2003, Dietary effect of different high-fat diet on rat liver stereology, Liver Int., 23, 363, 10.1034/j.1478-3231.2003.00858.x Magliano, 2013, Peroxisome proliferator-activated receptors-alpha and gamma are targets to treat offspring from maternal diet-induced obesity in mice, PLoS One, 8, e64258, 10.1371/journal.pone.0064258 Nakamura, 2013, Lessons from mouse models of high-fat diet-induced NAFLD, Int. J. Mol. Sci., 14, 21240, 10.3390/ijms141121240 Fraulob, 2010, A mouse model of metabolic syndrome: insulin resistance, fatty liver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL/6 mice fed a high fat diet, J. Clin. Biochem. Nutr., 46, 212, 10.3164/jcbn.09-83 Maury, 2010, Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome, Mol. Cell. Endocrinol., 314, 1, 10.1016/j.mce.2009.07.031 Briggs, 2013, Calorie-restricted weight loss reverses high-fat diet-induced ghrelin resistance, which contributes to rebound weight gain in a ghrelin-dependent manner, Endocrinology, 154, 709, 10.1210/en.2012-1421 Gustafson, 2007, Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis, Arterioscler. Thromb. Vasc. Biol., 27, 2276, 10.1161/ATVBAHA.107.147835 Van Wagner, 2011, The role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis, Ther. Adv. Gastroenterol., 4, 249, 10.1177/1756283X11403809 Tolman, 2011, The safety of thiazolidinediones, Expert Opin. Drug Saf., 10, 419, 10.1517/14740338.2011.534982 Souza-Mello, 2010, Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet, Clin. Sci. (Lond.), 119, 239, 10.1042/CS20100061 Festi, 2004, Hepatic steatosis in obese patients: clinical aspects and prognostic significance, Obes. Rev., 5, 27, 10.1111/j.1467-789X.2004.00126.x Cong, 2008, The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice, Life Sci., 82, 983, 10.1016/j.lfs.2008.01.022 Clemenz, 2008, Liver-specific peroxisome proliferator-activated receptor alpha target gene regulation by the angiotensin type 1 receptor blocker telmisartan, Diabetes, 57, 1405, 10.2337/db07-0839 Campbell, 2004, A novel function for fatty acid translocase (FAT)/CD36: involvement in long chain fatty acid transfer into the mitochondria, J. Biol. Chem., 279, 36235, 10.1074/jbc.M400566200 Serviddio, 2011, Oxidation of hepatic carnitine palmitoyl transferase-I (CPT-I) impairs fatty acid beta-oxidation in rats fed a methionine–choline deficient diet, PLoS One, 6, e24084, 10.1371/journal.pone.0024084 Lee, 2002, Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats, Biochem. Biophys. Res. Commun., 296, 293, 10.1016/S0006-291X(02)00822-7 Hammer, 1978, The role of lipid components of the diet in the regulation of the fatty acid composition of the rat liver endoplasmic reticulum and lipid peroxidation, Biochem. J., 174, 585, 10.1042/bj1740585 Zhou, 2008, Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis, Gastroenterology, 134, 556, 10.1053/j.gastro.2007.11.037 Frederico, 2011, Short-term inhibition of SREBP-1c expression reverses diet-induced non-alcoholic fatty liver disease in mice, Scand. J. Gastroenterol., 46, 1381, 10.3109/00365521.2011.613945 Cao, 2012, The C-681G polymorphism of the PPAR-gamma gene is associated with susceptibility to non-alcoholic fatty liver disease, Tohoku J. Exp. Med., 227, 253, 10.1620/tjem.227.253 Brunt, 1999, Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions, Am. J. Gastroenterol., 94, 2467, 10.1111/j.1572-0241.1999.01377.x Friedman, 2008, Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver, Physiol. Rev., 88, 125, 10.1152/physrev.00013.2007 Lee, 2011, Mechanisms of hepatic fibrogenesis, Best Pract. Res. Clin. Gastroenterol., 25, 195, 10.1016/j.bpg.2011.02.005 Hazra, 2004, Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells, J. Biol. Chem., 279, 11392, 10.1074/jbc.M310284200 Marra, 2000, Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells, Gastroenterology, 119, 466, 10.1053/gast.2000.9365 Galli, 2002, Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro, Gastroenterology, 122, 1924, 10.1053/gast.2002.33666 Kostadinova, 2012, GW501516-activated PPARbeta/delta promotes liver fibrosis via p38–JNK MAPK-induced hepatic stellate cell proliferation, Cell Biosci., 2, 34, 10.1186/2045-3701-2-34 Peters, 2011, Dissecting the role of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in colon, breast, and lung carcinogenesis, Cancer Metastasis Rev., 30, 619, 10.1007/s10555-011-9320-1